CanSino Biologics Inc. (6185.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.95B |
| Enterprise Value | 8B |
| P/E Ratio | 660.78 |
| PEG Ratio | 7.06 |
| Price/Sales Ratio | 11.03 |
| Price/Book Ratio | 3.75 |
| Enterprise/Revenue | 10.88 |
| Enterprise/EBITDA | 118.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | -0.01 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 1.03B |
| Revenue/Share | 5.09 |
| Gross Profit | 681.82M |
| EBITDA | 60.98M |
| Net Income | 27.15M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 1.77B |
| Total Cash/Share | 7.19 |
| Total Debt | 929.08M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 4.23 |
| Book Value Per Share | 20.27 |
Price History
| 52-Week Change | -40.38 |
| 52-Week High | 46.78 |
| 52-Week Low | 19.22 |
| Moving Average 50 Days | 29.49 |
| Moving Average 200 Days | 29.13 |
Statistics
| Average Volume | 6.69M |
| Shares Outstanding | 350.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
